Graham P. Allaway
No más puestos en curso
Historial de carrera de Graham P. Allaway
Antiguos cargos conocidos de Graham P. Allaway.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PANACOS PHARMACEUTICALS, INC. | Director de Operaciones | 27/02/2009 | 27/02/2009 |
| Fundador | 01/12/1992 | 27/02/2009 | |
Panacos Pharmaceuticals, Inc. /Old/
 Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection | Director de Operaciones | 03/03/2005 | 03/03/2005 |
| Presidente | - | 03/03/2005 | |
Manchester Biotech
 Manchester Biotech BiotechnologyHealth Technology Manchester Biotech is an American biotechnology company. | Presidente | 01/01/1997 | 01/01/1998 |
| PRESSURE BIOSCIENCES, INC. | Corporate Officer/Principal | 26/11/2009 | - |
Formación de Graham P. Allaway.
| University of Oxford | Graduate Degree |
| University of London | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Reino Unido | 3 |
Operativa
| President | 2 |
| Chief Operating Officer | 2 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PRESSURE BIOSCIENCES, INC. | Health Technology |
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Manchester Biotech
Manchester Biotech BiotechnologyHealth Technology Manchester Biotech is an American biotechnology company. | Health Technology |
Panacos Pharmaceuticals, Inc. /Old/
Panacos Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Panacos Pharmaceuticals is engaged in the discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos’ proprietary discovery technologies focus on novel targets in the virus life cycle, including virus fusion and virus maturation, the first and last steps of viral infection | Commercial Services |
- Bolsa de valores
- Insiders
- Graham P. Allaway
- Experiencia
